← Portfolio Scout

Portfolio company

CellFE

United States · £17.4m raised

Raised

£17.4m

Latest stage

Series A

Rounds recorded

1

Backed by

3 investors

Sectors

Deep TechB2B SaaSDigital Health

About

The company develops microfluidic platforms for intracellular delivery of molecules to support cell therapy developers and researchers in manufacturing engineered cells.

Source

Funding history · 1

Similar companies